Acrivon Therapeutics, Inc. - ACRV

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$38.07M
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
0.0%
Shares
Total shares
21,402,557
QoQ shares delta
0 (0.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ACRV)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
RA CAPITAL MANAGEMENT, L.P. 21,768 12,229,396 0.19%
Sands Capital Alternatives, LLC 4,074 2,289,271 0.66%
ACADIAN ASSET MANAGEMENT LLC 2,073 1,165,119 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 1,694 952,008 0.0%
WELLINGTON MANAGEMENT GROUP LLP 1,580 888,130 0.0%
RENAISSANCE TECHNOLOGIES LLC 1,350 758,863 0.0%
TWO SIGMA INVESTMENTS, LP 1,141 641,498 0.0%
MARSHALL WACE, LLP 946 531,856 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 674 378,900 0.01%
GEODE CAPITAL MANAGEMENT, LLC 472 265,241 0.0%
BlackRock, Inc. 425 239,112 0.0%
GSA CAPITAL PARTNERS LLP 357 200,415 0.02%
VANGUARD FIDUCIARY TRUST CO 327 184,128 0.0%
XTX Topco Ltd 317 178,239 0.0%
JANE STREET GROUP, LLC 132 74,648 0.0%
NORTHERN TRUST CORP 119 67,202 0.0%
STATE STREET CORP 119 67,145 0.0%
UBS Group AG 78 43,850 0.0%
CITADEL ADVISORS LLC 73 41,276 0.0%
DIMENSIONAL FUND ADVISORS LP 52 29,332 0.0%
Spark Investment Management LLC 50 28,300 0.1%
PRELUDE CAPITAL MANAGEMENT, LLC 42 24,015 0.0%
BANK OF AMERICA CORP /DE/ 29 16,407 0.0%
GOLDMAN SACHS GROUP INC 26 14,920 0.0%
Verdad Advisers, LP 26 15,054 0.02%